BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Biotrial to Call Newark Home, Will Create Hundreds of New Jobs


1/25/2013 8:06:00 AM

A French pharmaceutical research corporation that had been considering sites in New York and Boston to build its North American headquarters will soon break ground in an emerging mixed-use technology park in Newark adjacent to the University of Medicine and Dentistry of New Jersey, the New Jersey Institute of Technology and Rutgers University-Newark. Biotrial S.A. recently purchased a 1.2-acre parcel of land in University Heights Science Park, where more than 90 incubator companies are located within the 351,000 square feet of office and research space that already has been developed. As Biotrial hopes to occupy the new building in early 2014, New York-based architecture firm Francis Cauffman has completed the master design plan for the facility and expects to commence its construction this spring. Jean-Marc Gandon, president and chief executive offer of Biotrial, said in a statement the company needed “proximity to superior research and medical facilities and to a major transportation center” to expand in the United States, and it “looked at many locations around the world before deciding that Newark and University Heights Science Park best meet the many key requirements and standards we have for conducting our research.” In October 2011, the New Jersey Economic Development Authority board approved a $689,850 Business Employment Incentive Program grant for Biotrial S.A. to bring 60 jobs to Newark, though the board noted the incentive could increase to $1.2 million over 10 years if the company picked a site in the city over New York and Massachusetts. EDA spokeswoman Rachel Hartman said the agency has not yet determined the exact award amount because it is awaiting confirmation on the site selection from Biotrial, and the company would then need to submit other conditions for the BEIP.

Read at NJ Biz

NJ Biz
Biotrial
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES